Ultra-sensitive ELISAs for precise interferon and interleukin quantification across serum, plasma, and tissue culture media, validated for autoimmune, viral, and oncology research.

Cytoskeleton Inc. has been at the forefront of tubulin research since 1993, providing biologically active tubulin proteins, kits, and reagents to the scientific community.

Through our collaboration, Tebubio has brought these high-quality products to researchers across Europe, helping to unlock the complex dynamics of the cytoskeleton.

Reproducibility, physiological relevance, and streamlined workflows are key challenges in 3D cell culture research. Whether you’re modelling complex tissues, screening compounds, or investigating cell–matrix interactions, your success depends on reliable and easy-to-use systems that deliver consistent, biologically meaningful results.

To help you take your 3D models to the next level, Tebubio now offers innovative tools from two leading biotech partners, Apricell Biotechnology and 4Dcell, that deliver advanced solutions for spheroid and organoid formation, integrating seamlessly into your existing lab setup.

A new partnership has been established between Tebubio, a leading distributor of life science research reagents and services, and Apricell, an innovative company specializing in 3D cell culture technologies. This collaboration aims to broaden access to cutting-edge tools that support researchers working on 3D culture and organoid-based projects across Europe.

Tebubio, a European distributor of life science research reagents and services, partners with 4Dcell, a pioneering company specializing in the design of innovative cell culture environments. This collaboration aims to expand access to advanced technologies that support researchers working on 3D culture and organoid-based models.

Tebubio’s Célia Bosso-Lefevre, PhD, discusses in Technology Networks how in vitro oncology models provide ethical, predictive alternatives to animal testing and accelerate cancer research.

Our long-time partner, TriLink BioTechnologies, provides ligation-based technology that delivers highly pure, arrayed guide RNAs, offering the consistency and precision researchers need for reliable high-throughput screening and early discovery applications.

This exclusive monthly publication #12 brings you cutting-edge advancements and premium solutions from top suppliers in Oncology. Carefully curated to keep you at the forefront of your research, each issue will put under the spotlight breakthrough products, expert-led webinars, and essential resources to support your research needs from stimulus to models to analysis solutions.